"Revolutionizing Amyotrophic Lateral Sclerosis (ALS) Management: A Case Report on Muscle Regeneration and Sustained Relaxation through Placental Injection Therapy at Rodem Hospital"
Main Article Content
Abstract
This case report from the Rodem Hospital introduces a pioneering intervention for muscle rigidity in Amyotrophic Lateral Sclerosis (ALS), featuring a unique placental extract injection and glucose injection therapy combined with lidocaine. This novel approach has demonstrated significant muscle regeneration and sustained relaxation in 47 ALS patients. Unlike traditional treatments, this protocol offers a more sustainable and regenerative outcome. The treatment involved injections of a mixture containing glucose, lidocaine, and placental extract, targeting severely rigid muscles. Remarkably, 42 of the 47 patients showed considerable improvements in knee flexion and a dramatic reduction in pain. The other two also experienced notable progress. This method stands out for its cost efficiency, impact on muscle suppleness, and reduced pain, suggesting a potential paradigm shift in ALS management. This case series highlights the importance of continued innovation and personalized treatment strategies in ALS care, aiming to improve patient quality of life and functional abilities.
This case report from the Rodem Hospital introduces a pioneering intervention for muscle rigidity in Amyotrophic Lateral Sclerosis (ALS), featuring a unique placental extract injection and glucose injection therapy combined with lidocaine. This novel approach has demonstrated significant muscle regeneration and sustained relaxation in 47 ALS patients. Unlike traditional treatments, this protocol offers a more sustainable and regenerative outcome. The treatment involved injections of a mixture containing glucose, lidocaine, and placental extract, targeting severely rigid muscles. Remarkably, 42 of the 47 patients showed considerable improvements in knee flexion and a dramatic reduction in pain. The other two also experienced notable progress. This method stands out for its cost efficiency, impact on muscle suppleness, and reduced pain, suggesting a potential paradigm shift in ALS management. This case series highlights the importance of continued innovation and personalized treatment strategies in ALS care, aiming to improve patient quality of life and functional abilities.
Article Details
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
References
2. Ng L, Khan F, Young CA, Galea M. Symptomatic treatments for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database of Systematic Reviews. 2017;2017(1). doi:10.1002/14651858.CD011 776.pub2
3. Hobson E V., McDermott CJ. Supportive and symptomatic management of amyotrophic lateral sclerosis. Nat Rev Neurol. 2016; 12(9):526-538. doi:10.1038/NRNEUROL.2016.111
4. Supportive and symptomatic management of amyotrophic lateral sclerosis - PubMed. Accessed November 28, 2023. https://pubmed.ncbi.nlm.nih.gov/27514291/
5. Carter GT, Miller RG. Comprehensive management of amyotrophic lateral sclerosis. Phys Med Rehabil Clin N Am. 1998;9(1):271-284. doi:10.1016/s1047-9651(18)30290-0
6. Cudkowicz M, Qureshi M, Shefner J. Measures and markers in amyotrophic lateral sclerosis. NeuroRx. 2004;1(2):273-283. doi:10. 1602/NEURORX.1.2.273
7. Benbrika S, Desgranges B, Eustache F, Viader F. Cognitive, Emotional and Psychological Manifestations in Amyotrophic Lateral Sclerosis at Baseline and Overtime: A Review. Front Neurosci. 2019;13:951. doi:10. 3389/fnins.2019.00951
8. van Groenestijn AC, Kruitwagen-van Reenen ET, Visser-Meily JMA, van den Berg LH, Schröder CD. Associations between psychological factors and health-related quality of life and global quality of life in patients with ALS: A systematic review. Health Qual Life Outcomes. 2016;14(1). doi:10. 1186/s12955-016-0507-6
9. Park JH, Park HJ. Botulinum toxin for the treatment of neuropathic pain. Toxins (Basel). 2017;9(9). doi:10.3390/TOXINS9090260
10. Barnes M. Botulinum toxin - Mechanisms of action and clinical use in spasticity. J Rehabil Med Suppl. 2003;(41):56-59. doi:10. 1080/16501960310010151
11. Romito JW, Turner ER, Rosener JA, et al. Baclofen therapeutics, toxicity, and withdrawal: A narrative review. SAGE Open Med. 2021;9:20503121211022196. doi:10. 1177/20503121211022197
12. Ertzgaard P, Campo C, Calabrese A. Efficacy and safety of oral baclofen in the management of spasticity: A rationale for intrathecal baclofen. J Rehabil Med. 2017; 49(3):193-203. doi:10.2340/16501977-2211
13. Hasnat MJ, Rice JE. Intrathecal baclofen for treating spasticity in children with cerebral palsy. Cochrane Database of Systematic Reviews. 2015; 2015(11). doi:10.1002/1465 1858.CD004552.pub2
14. Buizer AI, Martens BHM, Grandbois van Ravenhorst C, Schoonmade LJ, Becher JG, Vermeulen RJ. Effect of continuous intrathecal baclofen therapy in children: a systematic review. Dev Med Child Neurol. 2019; 61(2):128-134. doi:10.1111/dmcn.14005
15. Calcaterra NE, Barrow JC. Classics in chemical neuroscience: Diazepam (valium). ACS Chem Neurosci. 2014; 5(4):253-260. doi: 10.1021/CN5000056
16. Pogozhykh O, Prokopyuk V, Figueiredo C, Pogozhykh D. Placenta and Placental Derivatives in Regenerative Therapies: Experimental Studies, History, and Prospects. Stem Cells Int. 2018; 2018. doi:10.1155/ 2018/4837930
17. Hong JW, Lee WJ, Hahn SB, Kim BJ, Lew DH. The effect of human placenta extract in a wound healing model. Ann Plast Surg. 2010; 65(1):96-100. doi:10.1097/SAP.0B013E3181B 0BB67
18. Joshi MG, Kshersagar J, Desai SR, Sharma S. Antiviral properties of placental growth factors: A novel therapeutic approach for COVID-19 treatment. Placenta. 2020;99: 117-130. doi:10.1016/J.PLACENTA.2020.07.033
19. Gwam C, Ohanele C, Hamby J, Chughtai N, Mufti Z, Ma X. Human placental extract: a potential therapeutic in treating osteoarthritis. Ann Transl Med. 2023; 11(9):322-322. doi:10. 21037/ATM.2019.10.20/COIF)
20. Gwam C, Ohanele C, Hamby J, Chughtai N, Mufti Z, Ma X. Human placental extract: a potential therapeutic in treating osteoarthritis. Ann Transl Med. 2023; 11(9):322-322. doi:10. 21037ATM.2019.10.20
21. Shen LH, Fan L, Zhang Y, et al. Protective Effect and Mechanism of Placenta Extract on Liver. Nutrients. 2022; 14(23). doi:10.3390/ NU14235071
22. Di Vincenzo O, Marra M, Di Gregorio A, Pasanisi F, Scalfi L. Bioelectrical impedance analysis (BIA) -derived phase angle in sarcopenia: A systematic review. Clinical Nutrition. 2021; 40(5):3052-3061. doi:10.1016 /j.clnu.2020.10.048
23. Hade MD, Suire CN, Suo Z. Mesenchymal Stem Cell-Derived Exosomes: Applications in Regenerative Medicine. Cells. 2021; 10(8). doi :10.3390/CELLS10081959
24. Mazzini L, Vescovi A, Cantello R, Gelati M, Vercelli A. Stem cells therapy for ALS. Expert Opin Biol Ther. 2016;16(2):187-199. doi:10.1517/14712598.2016.1116516
25. Giacomelli E, Vahsen BF, Calder EL, et al. Human stem cell models of neurodegeneration: From basic science of amyotrophic lateral sclerosis to clinical translation. Cell Stem Cell. 2022; 29(1):11-35. doi:10.1016/j.stem.2021.12.008
26. Najafi S, Najafi P, Farkhad NK, et al. Mesenchymal stem cell therapy in amyotrophic lateral sclerosis (ALS) patients: A comprehensive review of disease information and future perspectives. Iran J Basic Med Sci. 2023;26(8): 872-881. doi:10.22038/IJBMS.2023.66364.14572